These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2866786

  • 41. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C, Johnsson G, Regårdh CG.
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [Abstract] [Full Text] [Related]

  • 42. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L, Jänne J, Keyriläinen O, Koskinen P, Leskinen O, Pitkäjärvi T, Reinikainen M.
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
    Bertoni T, Alberti D, Peloso A, Francucci BM, De Ambroggi L.
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar 02; 26(3):148-52. PubMed ID: 2970442
    [Abstract] [Full Text] [Related]

  • 46. A double-blind study of oxprenolol once and twice daily in hypertensive patients.
    Glazer N, Friedman B, Gerlings E, Gross S, Lowney C, Solomon R.
    Clin Cardiol; 1983 Aug 02; 6(8):378-83. PubMed ID: 6352119
    [Abstract] [Full Text] [Related]

  • 47. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 48. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M, Agabiti-Rosei E, Carotti A, Innocenti P, Montervino C, Solinas E, Toso M, Muiesan G.
    Int J Clin Pharmacol Ther Toxicol; 1980 Aug 26; 18(8):332-7. PubMed ID: 7409934
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
    Willette RN, Mitchell MP, Ohlstein EH, Lukas MA, Ruffolo RR.
    Pharmacology; 1998 Jan 26; 56(1):30-6. PubMed ID: 9467185
    [Abstract] [Full Text] [Related]

  • 50. Effects of oxprenolol on the intra-arterial blood pressure response to dynamic exercise in hypertensive men.
    Millar-Craig MW, Mann S, Balasubramanian V, Cashman P, Raftery EB.
    J Cardiovasc Pharmacol; 1981 Jan 26; 3(3):468-76. PubMed ID: 6168828
    [Abstract] [Full Text] [Related]

  • 51. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R, Maclean D, Ioannides C, Johnston A, McDevitt DG.
    Br J Clin Pharmacol; 1988 Jul 26; 26(1):53-9. PubMed ID: 2904825
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Beta blockade in essential hypertension: an analysis of response to oxprenolol.
    Barritt DW, Marshall AJ.
    Br Heart J; 1977 Aug 26; 39(8):825-8. PubMed ID: 901673
    [Abstract] [Full Text] [Related]

  • 54. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC, Jeffers TA, Robb OJ, Scott AK, Webster J.
    Br Med J; 1980 Jun 28; 280(6231):1573-4. PubMed ID: 7000243
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA, Johnson SM, Tobian LJ.
    Clin Pharmacol Ther; 1979 Dec 28; 26(6):676-81. PubMed ID: 387330
    [Abstract] [Full Text] [Related]

  • 57. Experience with a slow-release formulation of oxprenolol.
    Waal-Manning HJ, Spears GF.
    N Z Med J; 1978 Apr 12; 87(609):245-6. PubMed ID: 275650
    [Abstract] [Full Text] [Related]

  • 58. A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
    Tuomilehto J.
    Acta Med Scand Suppl; 1979 Apr 12; 625():74-80. PubMed ID: 373397
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.